Management of metastatic neck disease – summary of the 11th Evidence Based Management Day
J. O'Hara
Sunderland Royal Hospital, Sunderland and Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorA. McQueen
Newcastle upon Tyne Hospitals, Newcastle-upon-Tyne, UK
Search for more papers by this authorC. Kelly
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorJ. Wilson
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorCorresponding Author
V. Paleri
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Correspondence: Vinidh Paleri, Department of Otolaryngology, Newcastle upon Tyne Hospitals and Newcastle University, Newcastle-Upon-Tyne, NE7 7DN, United Kingdom. e-mail: [email protected]Search for more papers by this authorJ. O'Hara
Sunderland Royal Hospital, Sunderland and Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorA. McQueen
Newcastle upon Tyne Hospitals, Newcastle-upon-Tyne, UK
Search for more papers by this authorC. Kelly
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorJ. Wilson
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Search for more papers by this authorCorresponding Author
V. Paleri
Newcastle upon Tyne Hospitals, Newcastle University, Newcastle-upon-Tyne, UK
Correspondence: Vinidh Paleri, Department of Otolaryngology, Newcastle upon Tyne Hospitals and Newcastle University, Newcastle-Upon-Tyne, NE7 7DN, United Kingdom. e-mail: [email protected]Search for more papers by this author
Supporting Information
| Filename | Description |
|---|---|
| coa12218-sup-0001-AppendixS1.docxWord document, 77.2 KB | Appendix S1. Evidence base and additional key references for each of the topics discussed on the EBM day |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1de Bondt R.B., Nelemans P.J., Hofman P.A. et al. (2007) Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur. J. Radiol. 64, 266–272
- 2Wu L.-M., Xu J.-R., Liu M.-J. et al. (2012) Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis. Acad. Radiol. 19, 331–340
- 3Kyzas P.A., Evangelou E., Denaxa-Kyza D. et al. (2008) 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J. Natl Cancer Inst. 100, 712–720
- 4Isles M.G., McConkey C. & Mehanna H.M. (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin. Otolaryngol. 33, 210–222
- 5Thompson C.F., St John M.A., Lawson G. et al. (2013) Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis. Eur. Arch. Otorhinolaryngol. 270, 2115–2122
- 6Rodrigo J.P., Maseda E., Maldonado M. et al. (2004) Efficacy of postoperative radiation therapy for squamous cell carcinoma of the head and neck: results of a prospective randomised clinical trial. Acta Otorrinolaringol. Esp. 55, 415–419
- 7Bernier J., Cooper J.S., Pajak T.F. et al. (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27, 843–850
Citing Literature
